Bank Of New York Mellon Corp Legend Biotech Corp Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$38.8 - $55.46 $5.68 Million - $8.12 Million	146,328 New	146,328 $7.3 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $403,398 - $603,775	10,574 Added 26.34%	50,714 $2.07 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $55.0 $75,129 - $123,200	2,240 Added 5.91%	40,140 $2.21 Million
Q1 2022 May 11, 2022	BUY	$31.02 - $48.18 $189,222 - $293,898	6,100 Added 19.18%	37,900 $1.38 Million
Q4 2021 Feb 11, 2022	BUY	$41.14 - $56.98 $1.31 Million - $1.81 Million	31,800 New	31,800 $1.48 Million

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.12B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.